How to read a prediction: determinate vs SCC ?
PhysioMap predicts the comparative-statics sign — the direction a quantity moves at the new steady state after all feedback has settled, sign(dx*/dθ) — not the naive forward product of edge signs along a path.
Determinate (↑ / ↓). The lesion drives the endophenotype one way regardless of the (unknown) reaction strengths — every numerical model consistent with the sign pattern agrees. PhysioMap commits to ↑ or ↓. These predictions are sound: validated against the real HPO gene→phenotype data, a determinate sign is never wrong.
SCC ? (magnitude-dependent). An SCC (strongly connected component) is a set of variables wired into a feedback loop — each reachable from the others. The largest homeostatic SCC in this map has exactly 213 nodes. When an endophenotype sits inside such a loop, opposing feedback arms fight, and the net steady-state sign depends on how strong each arm is — information a qualitative model does not have. Rather than guess, PhysioMap returns ? and abstains. The trace still shows the forward mechanism (e.g. “forward says ↑”), making explicit that steady state ≠ path propagation — getting pressure-natriuresis and the baroreflex right is exactly why we use comparative statics.
Honest abstention is a feature: PhysioMap reports a sign only when it is forced, so the ↑/↓ calls you do see are trustworthy.
| Disorder | Gene | OMIM | Endophenotypes (HPO) | |
| Liddle syndrome | SCNN1B / SCNN1G | 177200 | Hypertension, Hypokalemia, Decreased circulating renin concentration, Decreased circulating aldosterone concentration | SCC ? |
| Gitelman syndrome | SLC12A3 (NCC) | 263800 | Hypokalemia, Increased circulating renin concentration, Increased circulating aldosterone concentration, Hypotension, Elevated serum bicarbonate concentration | SCC ? |
| Bartter syndrome type 1 | SLC12A1 (NKCC2) | 601678 | Hypokalemia, Increased circulating renin concentration, Increased circulating aldosterone concentration, Elevated serum bicarbonate concentration | SCC ? |
| Glucocorticoid-remediable aldosteronism (FH type I) | CYP11B1/CYP11B2 chimera | 103900 | Hypertension, Hypokalemia, Decreased circulating renin concentration | SCC ? |
| 21-hydroxylase deficiency (classic salt-wasting CAH) | CYP21A2 | 201910 | Increased circulating ACTH level, Decreased circulating aldosterone concentration, Hyponatremia, Hyperkalemia, Hypotension | determinate |
| Familial hypercholesterolemia | LDLR | 143890 | Hypercholesterolemia | determinate |
| Hereditary hemochromatosis (HFE-related) | HFE | 235200 | Increased circulating iron concentration, Elevated transferrin saturation, Increased circulating ferritin concentration | determinate |
| Central diabetes insipidus | AVP | 125700 | High serum osmolality, Hypernatremia | SCC ? |
| Congenital hypothyroidism | TSHR / TPO | 218700 | Elevated circulating thyroid-stimulating hormone concentration, free_t3, Decreased resting energy expenditure, Bradycardia, Hypercholesterolemia | determinate |
| Phenylketonuria | PAH | 261600 | Hyperphenylalaninemia, Hypotyrosinemia | determinate |
| Classic homocystinuria | CBS | 236200 | Hyperhomocystinemia, Hypermethioninemia | determinate |
| Maple syrup urine disease | BCKDH | 248600 | Elevated circulating branched chain amino acid concentration | determinate |
| Lesch-Nyhan syndrome | HPRT1 | 300322 | Hyperuricemia | determinate |
| Hereditary xanthinuria | XDH | 278300 | Hypouricemia, Hyperxanthinemia | determinate |
| Glycogen storage disease type Ia (von Gierke) | G6PC | 232200 | Hypoglycemia, Lactic acidosis | determinate |
| Crigler-Najjar / Gilbert (UGT1A1) | UGT1A1 | 143500 | Unconjugated hyperbilirubinemia, plasma_conjugated_bilirubin | determinate |
| Wilson disease | ATP7B | 277900 | Decreased circulating ceruloplasmin concentration | SCC ? |
| X-linked hypophosphatemic rickets | PHEX | 307800 | Hypophosphatemia, Low serum calcitriol | SCC ? |